Compare CDXS & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDXS | CMT |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Electronic Components |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 161.1M |
| IPO Year | 2010 | N/A |
| Metric | CDXS | CMT |
|---|---|---|
| Price | $1.83 | $19.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 805.0K | 26.4K |
| Earning Date | 02-26-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $52,932,000.00 | ★ $261,619,000.00 |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | $5.23 | $6.66 |
| P/E Ratio | ★ N/A | $20.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $12.25 |
| 52 Week High | $5.43 | $22.29 |
| Indicator | CDXS | CMT |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 47.03 |
| Support Level | $1.61 | $18.10 |
| Resistance Level | $1.74 | $19.57 |
| Average True Range (ATR) | 0.08 | 0.81 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 92.59 | 44.09 |
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.